Avera Health and Sema4 Announce Collaboration to Advance Precision Oncology Care
Building on its commitment to genomic research and healthcare innovations, Avera Health will utilize Sema4’s health intelligence platform to further advance...
Month: August 2021
Quotient Limited Announces Departure of Chief Commercial Officer, Jeremy Stackawitz
JERSEY, Channel Islands, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), announced that...
Diffusion Pharmaceuticals Reports Q2 Financial Results and Provides Business Update
Reports Improved Outcomes in Phase 1b COVID-19 Study and Positive Trend in Peripheral Oxygenation in Phase 1b TCOM StudyExpects to Announce...
Avicanna Enters Partnership with Heritage Cannabis Holdings Corp. to Commercialize Evidence-Based Topical Products through Heritage’s Medical Cannabis Channels
Exclusive licensing of certain of Avicanna’s advanced and evidence-based CBD topical products including its deep tissue and skin care formulations.Heritage...
Wesana Health Commences Functional Animal Study for Treatment of Traumatic Brain Injury
TORONTO and CHICAGO, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB:...
Humacyte Announces Publication of In Vivo Data on Biovascular Pancreas Transplantation for the Treatment of Type 1 Diabetes
Data demonstrate biovascular pancreas may have the potential to provide an effective and safe method for pancreatic islet cell transplantation...
Kaleido Biosciences Reports Second Quarter 2021 Financial Results
--On track to report topline data from a clinical study of KB295 in patients with mild-to-moderate ulcerative colitis by end...
AEON Biopharma Announces the Appointment of Alex Wilson as General Counsel
NEWPORT BEACH, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc., a private clinical-stage biopharmaceutical company focused on the...
Helius Medical Technologies, Inc. Launches New Website for U.S.-Based Patients and Physicians
NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech...
scPharmaceuticals Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update
Received minutes from Type C meeting with the FDA confirming alignment on path toward resubmission of FUROSCIX® NDA; no additional...
Miromatrix Announces Key Strategic Investors to Advance the Development of Bioengineered Livers and Kidneys
The biotechnology company working to eliminate the organ transplant waitlist outlines expansion of its clinical work, supported by IPO funds...
Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
Completed a successful pre-IND meeting with the FDA for VRDN-001, a differentiated monoclonal antibody targeting IGF-1R for the treatment of...
FibroGen Receives Complete Response Letter from the FDA for Roxadustat for Anemia of Chronic Kidney Disease
SAN FRANCISCO, Aug. 11, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the U.S. Food and Drug Administration...
PolyPid Ltd. Reports Second Quarter 2021 Financial Results and Provides Corporate Update
• Recruitment Progressing as Planned with Over 300 Patients Enrolled into Phase 3 SHIELD I Trial of D-PLEX100 in Abdominal Surgery...
COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021
Highlights:Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end...
Immunocore Reports Second Quarter 2021 Financial Results and Provides Business Update
PRESS RELEASE Immunocore Reports Second Quarter 2021 Financial Results and Provides Business Update Biologics License Application (BLA) submission for tebentafusp...
Eve & Co Completes its Largest to Date Shipment of Cannabis to Germany
STRATHROY, Ontario, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE;...
Kamada Reports Second Quarter and First Half 2021 Financial Results, Recent Achievements and Corporate Development Activities
Second Quarter 2021 Revenues were $24.2 MillionIn Connection with the Transition of GLASSIA® Manufacturing, Kamada Largely Completed a Workforce Downsizing...
Retrotope Announces Completion of Enrollment in Phase 2 Study of RT001 in Patients with Progressive Supranuclear Palsy (PSP)
Target Enrollment for Study Surpassed in Less Than Six WeeksLOS ALTOS, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Retrotope, a...
Clene Enters into Two Leases to Materially Expand Manufacturing Capacity of its Lead Asset CNM-Au8®
Newly completed lease agreements to more than quadruple Clene’s manufacturing capacity to support ongoing clinical trials, future clinical trials and...
